chrisvoncsefalvay/vaers-outcomes huggingface dataset:
EVERY JOINT IN MY BODY BEGAN TO ACHE SEVERELY - KNEES, GROIN AREA, SHOULDERS, HANDS, ETC AND SHORTNESS OF BREATH / DRY COUGH
I got the shingles shot and now my lymph node under the injected arm is swollen.
2:00AM Vomited 3 times. 8:00AM had a seizure and fell over and my hands cramped up for 10 minutes after seizure. I lost control of my hands completely.
Patient recieve vaccine and is 17 years of age. Patient was monitored after vaccine for thirty minutes and no reaction was reported.
The clinic had received 400 pfizer vaccines, under the impression that these were the new bivalent vaccines. However, the vaccines that were received were the monovalent. The pt received the monovalent vaccine booster instead of the new one. The pt was informed.
mild case of COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (mild case of COVID) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    In September 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Dec-2022, the patient experienced COVID-19 (mild case of COVID). At the time of the report, COVID-19 (mild case of COVID) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   The patient had mild case of COVID-19 back the day before holiday last year. The patient had mild because of booster.  The concomitant medication was not reported.  The treatment medication was not reported.   Reporter did not allow further contact
Vomitting for 7 months, fatigue for 7 months, right knee swelling for 7 months, Blood work numbers sky rocketing, liver number sky rocketing, blood pressure very high.  All which were normal before shot.
Low fever, then rash started getting worse, raised red spots and rash around buttocks, arms, legs, feet, hands (varicella), constant screaming and itching at night; treated with children's Tylenol, Benadryl, and hydrocortisone cream.
A nurse reported that pt received vaccine 7/11/00, approximately 10 minutes post vaccine the pt developed hives and swelling at the injection site, with hives all over the leg.
Extreme fatigue, chills, fever on and off up to 101 degrees. Slight shortness of breath. Started Sunday April 11 at night with extreme fatigue. Monday evening started with chills and fever. Taking Tylenol to reduce fever
Patient had a large red swollen area on her arm - more than normal or expected. It was hot and itchy and spread over a day.
Patient received the Moderna COVID-19 vaccine on 1/14/2022. On 1/16/2022 patient was observed to have productive cough, shortness of breath, edema and warmth to left arm. Patient expired on 1/19/2022
bruise injection site left arm; lump below injection site left arm; pain slightly below injection site left arm; Fatigue; facial pain right side; Nausea; This is a spontaneous report from a contactable consumer, the patient. An elderly female patient of unspecified age received second dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) as a single dose in the left arm for COVID-19 immunisation on 25Mar2021. The patients medical history was not reported. Concomitant medications included low dose acetyl salicylic acid (asa) (MANUFACTURER UNKNOWN), atorvastatin calcium (LIPITOR), metoprolol (MANUFACTURER UNKNOWN), estrogens conjugated; medroxyprogesterone acetate (PREMPRO), paracetamol (TYLENOL) all taken for unknown indications within two weeks of vaccination. The patient had unspecified allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) on 04Mar2021. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021, the patient experienced bruise with lump and pain slightly below injection site left arm. Fatigue and facial pain right side. Briefly nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of all the events bruise injection site left arm, facial pain right side, fatigue, lump below injection site left arm, pain slightly below injection site left arm and nausea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant therapies were not reported. On 16-MAY-2016, the patient was vaccinated with a dose of PNEUMOVAX 23, lot # L002310, expiration date 08-JUL-2016, (route and anatomical location of administration were unspecified) which was improperly stored in refrigerator to temperatures excursion of 1.1 Celsius degrees for 920 hours and 0 Celsius degrees for 168 hours with lowest temperatures recorded of 34 and 32 Fahrenheit degrees respectively. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Wrist and elbow pain cant bend wrist never had a problem before...started feeling pain a few hours after shot and now its 2 day now and wrist feels like its getting worse
Reported feeling shaky and a racing heartbeat. Per the ED physician's notes, by the time patient was evaluated in the ED, her symptoms had resolved and she was released from care with no additional follow-up necessary.
COVID-19 Vaccine administered to adolescent; while giving her & mother discharge instructions, pallor set in quickly& she c/o nausea & feeling to vomit.  She was diaphoretic to touch, slow pulse <54.  While pulling out BP cuff, I gave her an emesis bag, she continued to have feelings of vomiting but never did.  11:40 AM 118/52 pulse slow but not fully counted. 11:42 AM P 56, RR 24, O2 98% Walked to cafeteria table to lie supine. During walk to table (less than 10 steps) her nausea ceased &color returned. 11:49 126/78 , P 62, RR 18, O2 100% ; Water given ; claims she felt much better. skin dry to touch and smiling. 11:53 AM sat  up and claims to "feel fine". 11:58 AM 128/72, P 66, RR12 , O2 99%  Claims to feel well, no nausea, skin dry to touch, pallor gone.  12:10 PM Released to mother, no further nausea, pallor or diaphoresis.
runny nose; body aches; fever; really really fatigue and usually I have alot of energy; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING (vomiting) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Past medical history not provided). Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RHINORRHEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING ( vomiting ). At the time of the report, RHINORRHOEA (runny nose), PAIN (body aches), PYREXIA (fever), FATIGUE (really really fatigue and usually I have alot of energy) and VOMITING ( vomiting ) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication taken by the patient was  Albuterol HFA inhaler, 2 puffs by mouth three times daily. Treatment information was not provided.
BLE DVTs April 28, 2021  followed by admission May 26, 2021 for PE and multiple embolic strokes
Kawasaki Disease. Received IVIG. (+) Coronary artery aneurysm. Dx and followed by ID + Cards.
Sudden Hearing Loss/Left Ear 04-05-2022 Oral Steroids prescribed by Clinic- (for Hearing disorders) 04-28-2022 Hyperbaric Oxygen treatments-05-21-2022 (30-straight days of 1-1/2  hour sessions)
This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 55-year-old female patient who received SHINGRIX for prophylaxis. On 7th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 7th June 2018, less than a day after receiving SHINGRIX, the patient experienced tiredness. On an unknown date, the outcome of the tiredness was recovered/resolved. It was unknown if the reporter considered the tiredness to be related to SHINGRIX. Additional details were received as follows: The patient reported that she felt tired for 2 days after vaccinating with SHINGRIX.
Patient reported that she felt dizzy and was nauseous. Patient requested 911 be called. Was feeling better but opted to go with ems for observation.
SX: arm red, swollen, itchy, painful starting 2 days after injection, lasting approximately 7 days. TX: cephalexin 500 mg one PO BID times 10 days, diphenhydramine 25 mg one PO PRN.
Initial report of an unsolicited case received on 27 December 2014 from a consumer, who is also the patient. A 66 year-old male patient with a history of MS had received on an unspecified date in October 2014 an INFLUENZA VACCINE (manufacturer, lot number, route and site of administration not reported) and on 21 December 2014, experienced a fever. On 27 December 2014, the patient reported that he went to the ER yesterday and was diagnosed with the flu. Treatment included TAMIFLU and concomitant medication included AUBAGIO. According to the patient although he was diagnosed with the flu, he did not feel he had normal flu symptoms other than the fever. No further information was provided at the time of the report. Outcome was unknown. Documents held by sender: none.
Pt received both Pneumovax 23 and Fluzone 2005 in left deltoid on her request  on 10/7/05. Over the weekend she experienced cold-like symptoms and redness that spread throughout the backside of her left arm. Pt saw family physician.
delirium started after first dose. Exacerbated greatly after second dose along with psychosis and deliriums.  Had to be admitted to geripsycyh unit and subsequently to long term care.
Within 15 minutes of administration arm felt heavy, "like it was asleep".  Within 1 hour tongue felt swollen, no difficulty swallowing or breathing.  Given 50mg of liquid Benadryl with symptoms resolved in 15 minutes.
Nauseous,  abdominal pain centered at the diaphragm. This is the same reaction I get with the erthrymiacin and vibramiacin but it was much milder. Also light headed.
As part of flu clinic  17 mo was given FLUMIST approved for equal to or greater than 2 year olds.  No reactions.
Excessive bleeding at injection; bruising > 2 weeks later. Pt. doesn't bruise easily. 5 weeks later, knot still felt in arm.
Soreness at injection site; Slight fever / fever (100.1 F); General fatigue; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 9 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 01Dec2021 15:30 (Lot number: FK5127) at the age of 9 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU, administration date 01Nov2021. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FK5618, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM, Route of Administration: Intramuscular), when the patient was 9 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 02Dec2021, outcome "recovered" (03Dec2021), described as "Soreness at injection site"; PYREXIA (non-serious) with onset 02Dec2021, outcome "recovered" (03Dec2021), described as "Slight fever / fever (100.1 F)"; FATIGUE (non-serious) with onset 02Dec2021, outcome "recovered" (03Dec2021), described as "General fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of vaccination site pain, pyrexia, fatigue.  Additional information: 18 hours after second shot, Patient woke up with soreness at injection site and slight fever. Was sent home from school 20 hours after 2nd injection with fever (100.1 F) and general fatigue. Fever and symptoms resolved by the following morning. Patient had no covid prior vaccination. Patient had no covid tested post vaccination. Patient had no Known allergies. The patient had received other vaccines within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Pt. received vaccines yesterday around 5 p.m. Today father came in with pt. to check his arm. Pt. had swelling, redness, and blisters around the location where vaccine were administered (left upper arm).
Myocarditis; Arrhythmia; Chillblains; This is a spontaneous report received from a contactable other Health Care Professional. A 70-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2, intramuscular, administered in left deltoid on 08Feb2021 (Lot Number: EL9265), at the age of 70 years, as a single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medications taken within two weeks of vaccination included vitamins nos, acetylsalicylic acid (ASPIRIN (E.C.), Vitamin D nos, metoprolol tartrate (LOPRESSOR), atorvastatin calcium (LIPITOR). Historical vaccine included BNT162b2, dose 1 on 14Jan2021, lot # EL3216, intramuscular in right deltoid. On an unspecified date, the patient experienced myocarditis, arrhythmia, and chilblains. The patient had lab tests which included haematology test: normal on 17Feb2021, clinical chemistry: normal on 17Feb2021, sars-cov-2 test negative: negative on 22Feb2021. The clinical outcome of the events myocarditis, arrhythmia, and chilblains was unknown.; Sender's Comments: Based on an implied vaccine-event chronological association, a causal relationship between reported events and PFIZER-BIONTECH COVID-19 mRNA VACCINE cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Childhood shot's on 4-13-04 at 10:00 AM - Mother returned with child at approx 3:20 om. Infant had rash (questionable hives) on left shoulder down left side of back in right elbow and around right eye. Child alert smiling no apparent distress in elbow & gave Benadryl 0.25 ml injection.
Began with slight swelling & pain at injection site.  Difficulty lifting arm above head.  Lasted about a week.  A couple weeks later there was itching, redness, and a lump at the site, lasting about a week, then subsiding. Another time, about 1 month post injection, the local reaction of itching, lump, redness resulted in clear fluid filled, pin head sized, blisters (reminded me of smallpox vaccination reaction).  There is now a darkened area, nickel to quarter size, that has not gone away.  During one flare-up there was a night time episode of a "croupy type" cough of short duration. The local reaction of itching, a palpable lump, some swelling, and redness, continues to occur at intervals of about 2 weeks, today, 4 months later.
Jan 14th - day of event: immediate dizziness Jan 15th-Jan 16th - low grade fever and fatigue (99.8-99.9) Jan 17th- Jan 21- stuffy, runny nose, mild sore throat Jan 22-23 - redness, mild itch, hot at the touch and dizziness
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 10-JUL-2013 The medical assistant reported patient was administered an expired dose of M-M-R II (0.5 ml, subcutaneous, lot # reported as 0870AA, exp 06-JUN-2013). The medical assistant was unsure if the patient had any previous doses of M-M-R II administered, however the patient had "negative titers for MMR antibodies" on an unspecified date prior to the expired dose of MMR being administered. No adverse effect reported. Additional information has been requested.
Disruption to menstrual cycles following receipt of J&J vaccine. Cycles have ranged in length from 50 days in length, to as little as 19 which is not typical for me. Cycles have become increasingly prolonged, heavier and uncomfortable. Cycles have not settled back to usual as yet.  Note: For Item 21 below, I chose 'none of the above' as I did not have an in person visit with my doctor regarding this issue. However, I discuss it with her on phone/email.
Moderna vaccine was administered outside of clinic- reported by patient ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------ HYPOTENSION 4/26/2023 HYPOTENSION HYPOTENSION 4/26/2023 HYPOGLYCEMIA
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Additional Details: patient used epipen on themselves at home after leaving the store.
Patient states that evening she developed swelling in her left arm from her shoulder to her elbow. Her elbow was swollen and stiff and states it was difficult to move her arm. She also states she had stabbing sharp pain in her left bicep when she attempted to move her arm. Her arm became hot to touch and she developed what she described as a "prickly rash" from her shoulder to her elbow. She felt ill all day the next day. She states the reaction and swelling cleared up within 4-5 days.
stomachache; woke up several hour late and started to throw up(total of four times); developed a fever 99.3; headache; headache; lethargic; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LETHARGY (lethargic), ABDOMINAL PAIN UPPER (stomachache), the first episode of HEADACHE (headache), VOMITING (woke up several hour late and started to throw up(total of four times)) and PYREXIA (developed a fever 99.3) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced LETHARGY (lethargic) and the first episode of HEADACHE (headache). On 31-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomachache), VOMITING (woke up several hour late and started to throw up(total of four times)), PYREXIA (developed a fever 99.3) and the second episode of HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) on 30-Mar-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, LETHARGY (lethargic), ABDOMINAL PAIN UPPER (stomachache), VOMITING (woke up several hour late and started to throw up(total of four times)), PYREXIA (developed a fever 99.3) and the last episode of HEADACHE (headache) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Body temperature: 99.3 (High) 99.3.         Concomitant medications were not provided. Other treatment medications included cold compresses and Pedialyte.
Patient experienced syncope and sweating a few minutes after vaccination.   He recovered immediately and experienced no further symptoms for the remainder of the observation period.
This case was reported by a pharmacist via a claims benefit management company and described the occurrence of adverse reaction in a female subject of unspecified age who was vaccinated with TWINRIX (GlaxoSmithKline), typhoid vaccine (non-gsk). On 8 November 2013 the subject received unspecified dose of TWINRIX (unknown details), unspecified dose of Typhoid vaccine (Non-GSK) (unknown details). On an unspecified date in 2013, within months of vaccination with TWINRIX and Typhoid vaccine (Non-GSK), the subject experienced adverse reaction. At the time of reporting the outcome of the event was unspecified.
On Wednesday, March 31, 2021 client (DOB 4/30/1992) received her first dose of Pfizer COVID vaccine (LOT # EW0150, EXP 7/2021) at approximately 11:50 am by vaccinator RN. RN instructed client to self-monitored at the observation area. EMTs  found a 28 years old female sitting up while leaning forward and waving for assistance in an observation chair. Client had a chief complaint of dizziness. Client reported dizziness and fatigue to EMTs present after having sat in the observation area for approximately 10 minutes. Client had no known allergies or major medical history. Client denied pregnancy. Client agreed to be assisted walking up to the front EMT station so that she may be assessed more closely and with greater privacy. While walking over to the EMT station, the client experienced sudden loss in weight bearing and was prevented from falling by EMT present. EMT promptly came over to assist with transferring the patient to a chair for safety. Client was kept safe in her chair by EMT. It was at this point client experienced syncope. Client was then transferred to the gravity bed and laid supine until she became more alert. Client was then transferred to sitting semi-fowlers at 45 degrees once she was alert and tracking. lead RN came to assist EMTs as needed. Assessment revealed no hives, swelling, redness, difficulty breathing, wheezing or pain throughout her body. Client's skin was free of any signs of anaphylaxis throughout her body. Client's first set of vitals at 11:50 am was as follows: blood pressure 100 / 64, O2 - 99% on room air, pulse was 64 and regular at radial, respirations was 20 and regular. Client was fully alert and oriented x 4 (person, place, time, situation) and eyes were equal and reactive to light. Client stated that she had breakfast and denied any pain throughout her body. Client agreed to stay in the observation area for another 30 minutes after the onset of the incident per lead nurse?s instruction to EMT. Client's vitals were reassessed at 5 minutes intervals as follows: 11:50 am- 110/64 (BP), 20 (respirations), 64 (pulse), 99% (O2); 11:55 am- 102/64, 18, 64, 99%; 12:00 pm - 104/ 68, 72, 18, 99%; 12:05 pm - 118/ 72, 72, 16, 100%; 12:10 pm - 118/ 78, 99%, 16, 78; 12:15 pm - 118/ 78, 100%, 16, 78; 12:20 pm - 118/80, 100%, 16, 78. After approximately 10 minutes, the client was asked to sit up so that her orthostatic vitals could be reassessed. Throughout her observation, client's vitals slowly returning to normal with a blood pressure - 118/ 80, pulse 78, respirations 16 and 02 100% on room air. Client was provided with a fact sheet and pertinent areas of interest were highlighted for convenience. Client stated that she felt safe going home and ordered a ride sharing service. Client was encouraged to follow up with her primary and to seek medical care or the emergency room if a severe incident occurs. At 12:35 pm, the client departed the facility in a ride sharing service in no apparent distress and with all relevant information in her purse.
Patient had a syncope event and grand mal seizure approximately 2 minutes post vaccination. Seizure activity lasting less than 1 minute.